Literature DB >> 22644838

Mutations in the AVPR2, AVP-NPII, and AQP2 genes in Turkish patients with diabetes insipidus.

Duygu Duzenli1, Emel Saglar, Ferhat Deniz, Omer Azal, Beril Erdem, Hatice Mergen.   

Abstract

The aim of this study was to identify mutations in three different genes, the arginine-vasopressin-neurophysin II (AVP-NPII) gene, the arginine-vasopressin receptor 2 (AVPR2) gene, and the vasopressin-sensitive water channel aquaporin-2 (AQP2) gene in Turkish patients affected by central diabetes insipidus or nephrogenic diabetes insipidus. This study included 15 patients from unrelated families. Prospective clinical data were collected for all patients including the patients underwent a water deprivation-desmopressin test. The coding regions of the AVPR2, AQP2, and AVP-NPII genes were amplified by polymerase chain reaction and submitted to direct sequence analysis. Of the 15 patients with diabetes insipidus referred to Gulhane Military Medical Academy, Department of Endocrinology and Metabolism, eight patients have AVPR2 mutations, five patients have AQP2 mutations and two patients have AVP-NPII mutations. Of the patients, which have AVPR2 mutations, one is compound heterozygous for AVPR2 gene. Seven of these mutations are novel. Comparison of the clinical outcomes of these mutations may facilitate in understanding the functions of AVP-NPII, AQP2, and AVPR2 genes in future studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22644838     DOI: 10.1007/s12020-012-9704-1

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  26 in total

Review 1.  The evolutionary origin of the vasopressin/V2-type receptor/aquaporin axis and the urine-concentrating mechanism.

Authors:  Kristian Vinter Juul
Journal:  Endocrine       Date:  2012-02-29       Impact factor: 3.633

Review 2.  Molecular biology of hereditary diabetes insipidus.

Authors:  T Mary Fujiwara; Daniel G Bichet
Journal:  J Am Soc Nephrol       Date:  2005-08-10       Impact factor: 10.121

3.  Novel mutations in the V2 vasopressin receptor gene of patients with X-linked nephrogenic diabetes insipidus.

Authors:  D Wenkert; J J Merendino; A Shenker; N Thambi; G L Robertson; A M Moses; A M Spiegel
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

Review 4.  Molecular and cellular defects in nephrogenic diabetes insipidus.

Authors:  N V Knoers; P M Deen
Journal:  Pediatr Nephrol       Date:  2001-12       Impact factor: 3.714

5.  Lithium toxicity: an iatrogenic problem in susceptible individuals.

Authors:  P W Oakley; I M Whyte; G L Carter
Journal:  Aust N Z J Psychiatry       Date:  2001-12       Impact factor: 5.744

Review 6.  Diabetes insipidus: clinical and basic aspects.

Authors:  Joseph A Majzoub; Abhinash Srivatsa
Journal:  Pediatr Endocrinol Rev       Date:  2006-12

Review 7.  Diabetes insipidus: diagnosis and treatment of a complex disease.

Authors:  Amgad N Makaryus; Samy I McFarlane
Journal:  Cleve Clin J Med       Date:  2006-01       Impact factor: 2.321

8.  Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus.

Authors:  Sayali A Ranadive; Baran Ersoy; Helene Favre; Clement C Cheung; Stephen M Rosenthal; Walter L Miller; Christian Vaisse
Journal:  Clin Endocrinol (Oxf)       Date:  2008-12-18       Impact factor: 3.478

9.  Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus.

Authors:  D G Bichet; M Birnbaumer; M Lonergan; M F Arthus; W Rosenthal; P Goodyer; H Nivet; S Benoit; P Giampietro; S Simonetti
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

10.  A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus.

Authors:  M Ito; Y Mori; Y Oiso; H Saito
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

View more
  8 in total

1.  A large deletion of the AVPR2 gene causing severe nephrogenic diabetes insipidus in a Turkish family.

Authors:  Emel Saglar; Ferhat Deniz; Beril Erdem; Tugce Karaduman; Arif Yönem; Eylem Cagiltay; Hatice Mergen
Journal:  Endocrine       Date:  2013-09-13       Impact factor: 3.633

2.  Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.

Authors:  Alejandro García Castaño; Gustavo Pérez de Nanclares; Leire Madariaga; Mireia Aguirre; Sara Chocron; Alvaro Madrid; Francisco Javier Lafita Tejedor; Mercedes Gil Campos; Jaime Sánchez Del Pozo; Rafael Ruiz Cano; Mar Espino; Jose Maria Gomez Vida; Fernando Santos; Victor Manuel García Nieto; Reyner Loza; Luis Miguel Rodríguez; Emilia Hidalgo Barquero; Nikoleta Printza; Juan Antonio Camacho; Luis Castaño; Gema Ariceta
Journal:  Eur J Pediatr       Date:  2015-04-23       Impact factor: 3.183

Review 3.  Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus.

Authors:  Detlef Bockenhauer; Daniel G Bichet
Journal:  Nat Rev Nephrol       Date:  2015-06-16       Impact factor: 28.314

4.  A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation.

Authors:  Li Zang; Yuping Gong; Yijun Li; Jingtao Dou; Zhaohui Lyu; Xiaoqing Su; Yawei Zhang; Yiming Mu
Journal:  Biomed Res Int       Date:  2022-07-12       Impact factor: 3.246

5.  Functional analyses of three different mutations in the AVP-NPII gene causing familial neurohypophyseal diabetes insipidus.

Authors:  Merve Özcan Türkmen; Tugce Karaduman; Beril Erdem Tuncdemir; Mehmet Altay Ünal; Hatice Mergen
Journal:  Endocrine       Date:  2021-07-07       Impact factor: 3.633

6.  Functional characterization of AVPR2 mutants found in Turkish patients with nephrogenic diabetes insipidus.

Authors:  Beril Erdem; Angela Schulz; Emel Saglar; Ferhat Deniz; Torsten Schöneberg; Hatice Mergen
Journal:  Endocr Connect       Date:  2017-11-08       Impact factor: 3.335

Review 7.  AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.

Authors:  Chao Gao; Paul J Higgins; Wenzheng Zhang
Journal:  Cells       Date:  2020-09-26       Impact factor: 6.600

Review 8.  An Insight into GPCR and G-Proteins as Cancer Drivers.

Authors:  Preeti Kumari Chaudhary; Soochong Kim
Journal:  Cells       Date:  2021-11-24       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.